小细胞肺癌转分:不是一个可以忽略不计的现象
Lilla Horvath1,2, Kristiina Boettiger3, Zsolt Megyesfalvi1,2,3
1National Koranyi Institute of Pulmonology.
Current opinion in oncology
|November 20, 2025
概括
小细胞肺癌 (SCLC) 转差异化是积极的,难以诊断的. 本综述详细介绍了这种侵袭性肺癌亚型的分子驱动因素和治疗挑战.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 癌症研究 癌症研究
背景情况:
- 小细胞肺癌 (SCLC) 具有侵略性,预后不佳.
- 转基因转化为SCLC存在诊断方面的挑战.
- 对于SCLC转差异化的非侵入性预测因素是有限的.
研究的目的:
- 审查目前对SCLC转分化的理解.
- 探索驱动这种现象的分子机制.
- 讨论治疗转基因SCLC的挑战.
主要方法:
- 对回顾性研究和案例报告的文献综述.
- 对SCLC转分化背后的分子机制的分析.
- 关于SCLC转分化的当前知识的综合.
主要成果:
- 在非小细胞肺癌 (NSCLC) 发生EGFR突变,ALK重组或RET融合后,可以发生SCLC转分化.
- 在免疫治疗或辐射后的EGFR野生型NSCLC中也观察到转基因分化.
- 已经确定了SCLC转分化的几个分子驱动因素.
结论:
- 了解SCLC转分化对于改善患者的治疗结果至关重要.
- 转基因SCLC的治疗仍然是一个重大的临床挑战.
- 目前正在进行的研究正在探索这种侵袭性癌症的新疗法策略.
相关概念视频
01:28Forced Transdifferentiation
2.3K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.3K
02:40Cancer Stem Cells and Tumor Maintenance
5.8K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K